Zions Bancorporation’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $4.91K | Hold |
371
| – | – | ﹤0.01% | 707 |
|
|
2024
Q3 | $5.28K | Buy |
371
+152
| +69% | +$2.16K | ﹤0.01% | 705 |
|
|
2024
Q2 | $2.83K | Sell |
219
-250
| -53% | -$3.24K | ﹤0.01% | 816 |
|
|
2024
Q1 | $6.51K | Hold |
469
| – | – | ﹤0.01% | 721 |
|
|
2023
Q4 | $6.69K | Hold |
469
| – | – | ﹤0.01% | 712 |
|
|
2023
Q3 | $7.26K | Sell |
469
-83
| -15% | -$1.28K | ﹤0.01% | 683 |
|
|
2023
Q2 | $8.67K | Sell |
552
-144
| -21% | -$2.26K | ﹤0.01% | 660 |
|
|
2023
Q1 | $11.5K | Buy |
696
+8
| +1% | +$132 | ﹤0.01% | 620 |
|
|
2022
Q4 | $10.7K | Buy |
688
+469
| +214% | +$7.32K | ﹤0.01% | 693 |
|
|
2022
Q3 | $3K | Sell |
219
-47
| -18% | -$644 | ﹤0.01% | 845 |
|
|
2022
Q2 | $4K | Sell |
266
-374
| -58% | -$5.62K | ﹤0.01% | 904 |
|
|
2022
Q1 | $9K | Buy |
640
+383
| +149% | +$5.39K | ﹤0.01% | 847 |
|
|
2021
Q4 | $4K | Sell |
257
-307
| -54% | -$4.78K | ﹤0.01% | 876 |
|
|
2021
Q3 | $9K | Sell |
564
-287
| -34% | -$4.58K | ﹤0.01% | 752 |
|
|
2021
Q2 | $14K | Sell |
851
-445
| -34% | -$7.32K | ﹤0.01% | 664 |
|
|
2021
Q1 | $24K | Sell |
1,296
-43
| -3% | -$796 | ﹤0.01% | 545 |
|
|
2020
Q4 | $24K | Sell |
1,339
-964
| -42% | -$17.3K | ﹤0.01% | 526 |
|
|
2020
Q3 | $41K | Buy |
2,303
+1,909
| +485% | +$34K | 0.01% | 411 |
|
|
2020
Q2 | $7K | Sell |
394
-806
| -67% | -$14.3K | ﹤0.01% | 704 |
|
|
2020
Q1 | $18K | Buy |
1,200
+185
| +18% | +$2.78K | ﹤0.01% | 484 |
|
|
2019
Q4 | $20K | Buy |
1,015
+47
| +5% | +$926 | ﹤0.01% | 606 |
|
|
2019
Q3 | $17K | Buy |
968
+185
| +24% | +$3.25K | ﹤0.01% | 619 |
|
|
2019
Q2 | $14K | Sell |
783
-2,001
| -72% | -$35.8K | ﹤0.01% | 598 |
|
|
2019
Q1 | $57K | Buy |
+2,784
| New | +$57K | 0.01% | 388 |
|